• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex CFO Announces Retirement

    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning

    First Reported Use of Pulse Biosciences' CellFX System

    EUA Granted for New COVID-19, Flu A, Flu B Combo Kit

    EchoNous Expands Its Kosmos Hardware Platform
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cybersecurity Compromises, Courtesy of COVID-19

    A Look at the Actual Device Costs for Hospitals

    Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

    FDA Making Progress With Technology and Data Action Plans

    What’s Hot Now in Medtech M&A
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    Forefront Medical Technology

    MW Life Sciences

    Unicep
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Creganna Medical, part of TE Connectivity

    Concise Engineering

    Spectrum Plastics Group

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Non-Traditional Thinking Can Help Drive Medtech R&D

    Non-healthcare-related companies like Google, Amazon, and Apple can provide the medtech industry with unique solutions to age-old problems.

    Non-Traditional Thinking Can Help Drive Medtech R&D
    Image courtesy of Element Materials Technology.
    Related CONTENT
    • Extractables & Leachables
    • Element Material Technology Acquires Avomeen
    Michael Barbella, Managing Editor04.21.20
    It will be different next time. Much different, hopefully.
     
    Future pandemics are unlikely to resemble the disjointed patchwork of COVID-19 mitigation efforts implemented worldwide by lawmakers and health officials. Instead, they possibly will involve more coordinated responses and widespread testing, as well as technological innovations inspired by design thinking.
     
    Such thinking could result in redesigned public spaces that double as treatment areas during an outbreak and airports with more security screening lanes. Hospitals are likely to rethink conventional schematics too, potentially employing such pandemic-busting features as negative pressure zones, special patient evaluation areas, telehealth centers, and flexible-use rooms (i.e., those easily modified between acute care and ICU).
     
    With the COVID-19 threat unlikely to abate in the fore- seeable future, design thinking could potentially become a powerful tool in helping to better manage and control forthcoming pandemics. The approach is already being used to improve healthcare equity and spawn creative solutions to medicine’s most pressing dilemmas.
     
    MPO’s January/February feature, “Inventive Interaction,” explores the various forces at play in medtech R&D. Maciej Jakucki, medical device manager at Element Materials Technology., was among the various experts interviewed for the story. His full input is provided in the following Q&A.
     
    Michael Barbella: Where are companies spending their research dollars now—on incremental improvements to existing devices, or game-changing innovation?
    Maciej Jakucki: Incremental changes will always be a part of R&D and I think it depends on the amount of risk that a company is willing to tolerate. In orthopedics, two innovative areas are additive and robotics and they continue to drive the growth in the industry—focusing on replicating existing product lines with additive manufacturing, but then also leveraging those unique capabilities to improve geometries. All of the largest companies have invested in robotics to improve patient outcomes, and new robotic technology continues to be developed. Is this expensive? Yes. Is it game changing and does this functionally change the industry right now or prove better patient outcomes? I think it has the potential to, but in my opinion, it is still several years away from being game changing. When you look at life saving product development in the diagnostic or cardiovascular segments, companies are more likely to spend their R&D dollars on introducing game changing innovation using technology such as wireless, imaging, augmented reality, machine learning and artificial intelligence—especially if the market growth continues. Many of the cardiovascular medical device projects we see are brand new device designs or solutions for complex problems. Looking into 2020, there is potential for more innovation and introduction of game changing technology; however, with MDR, the upcoming political election and uncertain tax legislature, there is potential for companies to reduce spending dollars as they protect themselves from risk.
     
    Barbella: How is value-based healthcare shaping the kinds of medical devices/technology being developed?
    Jakucki: If we could measure what comes out of the body, then we could improve and better understand what to put into our bodies. With value-based healthcare, healthcare delivery systems, device and health feedback models and patient monitoring are critical to success. This will continue to drive software advances alongside of medical devices. If you couple that data with predictive analytics, you can impact it even more and start closing the loop. The question really becomes: “Which metrics?” The explosion in cloud computing, predictive AI, and data analysis software will result in medical technology of the future communicating and predicting health patterns, as well as provide updated training based on real time events. A heavier industry focus on clinical results and making data available will spill over into all of the regulatory environments. The industry is also seeing more “non-medical” companies use their expertise to align and partner with the traditional medical device companies or even strike out on their own. Imagine companies not only being in the business of developing and selling medical devices, but also then selling the data they have obtained which in turn will be used to drive new technology development.
     
    Barbella: Please discuss the importance of university/academic partnerships in developing cutting-edge medical devices.
    Jakucki: Partnership with academia is critical for development of future devices. In my mind, there are two main areas where this is applicable. The first is training new talent and routing into the industry hotbeds. I came through Drexel University where I spent time in pharma, power, and medical device industries as a co-op and expanded my worldviews in each. I still remember differences that have influenced decision making because of the exposure I received. Active co-op and internship programs offer accelerated ramp-up time so new graduates hit the ground running, especially if afforded the opportunity to have interned at medical device companies. Your new employee starts with two years of experience at your company already. Second, if those universities are also performing both basic and applied research in relevant medical device technology where they can drive talent into specific fields, those perspectives and relationships can help drive new innovation at the industry level. A results-oriented, collaborative approach helps discovery on both the academic and industry level. Academia needs to solicit and engage with industry to go from concept to market, and industry needs to be in better touch with the new talent and opportunities across the board, not just in the medical space, but also in other cutting-edge industries to bring new perspectives.
     
    Barbella: Are startups better suited than their mid-size or large OEM cohorts to develop medical technology that addresses value-based healthcare solutions? If so, how? (Or, if not, why not?)
    Jakucki: Absolutely. The large OEMs have a significant amount of talent to deliver truly innovative ideas, but the business impact of having to report quarterly profits and the risk of a negative press release by an unproven technology is a concern. I wonder how many ideas don’t get pursued. It is typically better for a large company to incrementally develop and then either acquire or partner with a smaller, more nimble company, essentially outsourced the innovative R&D. That way, the risk can be assumed separately and then once vetted, bring the best technology internally surrounded by large OEM expertise. Speaking of developing medical technology, with the ability to stay connected through social media, crowd funding, and the venture capital money available, I think there is opportunity for grassroots problem solving to start developing new technology to disrupt common thinking. In terms of value-based solutions, it can be difficult for a large OEM to stay connected on the patient ground level to the same extent as a smaller company. If a disruptive technology can be developed and then combined with the resources and expertise available at the large company level, then value-based care can really be improved.
     
    Barbella: Can a company effective tackle a healthcare need/problem and devise a solution based on its own internal R&D? Please explain.
    Jakucki: I think innovation and problem solving follow the ability to think across industries and solicit ideas from people that don’t think like you. One of the developments in healthcare that excites me is to see companies like Google, Amazon, Apple, and Facebook—non-traditional medical companies—dip their toes into the medical space or partner with medical companies to drive ideas forward. I see this progress every day in our product testing laboratories. There are innovative medical device companies that are able to devise solutions through their own R&D, but most are adding a “me too” device or relying on a very niche market. If game-changing innovation is the target, I think this is difficult to perform internally.
     
    Barbella: How can companies “innovate the process of innovation” to achieve more transformational products through R&D?
    Jakucki: Coming from a testing company with a global presence in medical, aerospace, automotive, energy, etc., it is really interesting to see how each industry is different and I think medical would benefit substantially by cross pollinating and bringing different skills from other industries. I keep hearing comments about how small the medical device industry is, and the same people just move around from company to company. While this is great for incremental improvement, can you really drive development of transformational products by thinking the same way?
     
    Barbella: How will AI, big data, and digital health affect the R&D process going forward?
    Jakucki: Transformative. It challenges contemporary analytical techniques and creates new models that were previously unable to factor in different variables. To be able to use past, present and predicted data also transforms the way R&D functions. Instead of targeting a specialty skillset, integrating advanced backgrounds in statistics or computing will be necessary to keep up with your competition. As new data models are created and become readily available, the ability of R&D to pivot will become critical as the current models can lock in on a target and miss the signs along the way to make an adjustment. Data-hungry processes will also force increased collaboration with different industries
     
    Barbella: What is driving the need to outsource medtech R&D? Does the R&D process even need to be outsourced?
    Jakucki: I mentioned that R&D expands and contracts with business needs. If you diversify your product portfolio, it can be a challenge to use the same team and, depending on your growth, to keep that team engaged. It is also expensive to hire specialized talent, and that talent has be able to grow and pivot with the company. For a smaller company, they can’t necessarily afford to bring on all the necessary experts so they have to decide on what is least prohibitive. Increase the timeline? Risk adding the expertise? Hire temps or partner with someone who can provide the resources so the business can focus on their core strengths? It also depends on the technology you are pursuing and how long it will take to implement. In our testing business, we have seen some customers increase their R&D outsourcing over the last year. It is also becoming more common for services like quality and regulatory to be outsourced as well. With upcoming increased regulation, the political and tax environment, and the uncertainty of the future economy, outsourcing some or most of your R&D seems like an appropriate option.
    Related Searches
    • mpo
    • quality
    • cloud
    • development
    Suggested For You
    Extractables & Leachables Extractables & Leachables
    Element Material Technology Acquires Avomeen Element Material Technology Acquires Avomeen

    Related Online Exclusives

    • How Grant Funding Works and How It Can Help

      How Grant Funding Works and How It Can Help

      Gaining additional funds for a medical device project can go a long way for a company in the early stages of development.
      Libby Hikind, Founder & CEO, GrantWatch.com 03.01.21

    • Electronics | Testing
      Refurbished Medical Equipment Testing and Certification Under the NEC

      Refurbished Medical Equipment Testing and Certification Under the NEC

      The National Electric Code (NEC) has been updated to better ensure refurbished or reconditioned products' safety and performance.
      L. Matthew Snyder, Director of Certification, Intertek 02.25.21

    • Contract Manufacturing | Machining & Laser Processing
      Taking the First Step with Metal Components

      Taking the First Step with Metal Components

      With a foundation in stamping and machining services, Hobson & Motzer offers a revolutionary approach to new product development.
      Sean Fenske, Editor-in-Chief 02.19.21


    • 4 Trends Driving Medical Manufacturing in 2021

      4 Trends Driving Medical Manufacturing in 2021

      Manufacturers across the sector had to manage disruptions last year, but economists say recovery may begin soon.
      Emily Newton, Editor-in-Chief, Revolutionized 02.16.21

    • Diagnostics | Digital Health | Software & IT
      Pioneering AI Solutions to Reinforce Healthcare Services

      Pioneering AI Solutions to Reinforce Healthcare Services

      Can AI live up to its hype in the healthcare landscape?
      Sunil Jha, Senior Research Content Developer, Global Market Insights 02.12.21

    • The 8 Major Types of PPE Supply Chain Fraud

      The 8 Major Types of PPE Supply Chain Fraud

      Medical device manufacturers need to be aware of what’s happening within the space if they are making protection equipment themselves.
      Richie M. Hecker, Managing Director, TS Health Supplies Division, Traction & Scale LLC 02.10.21


    • Digital Health
      Evolving Trends in the Medical and Orthopedic Devices Industry

      Evolving Trends in the Medical and Orthopedic Devices Industry

      There are a number of areas worth keeping an eye on within medtech in 2021 and beyond.
      Jacqueline Trovato, Healthcare/Legal Writer 02.09.21

    • Perspectives on Post-Pandemic: Near-Sourcing Will Gain Traction

      Perspectives on Post-Pandemic: Near-Sourcing Will Gain Traction

      Philip Katen of Plastikos believes medical device manufacturers will look to local sources for manufacturing and component needs.
      Philip Katen, General Manager and President, Plastikos, Plastikos Medical, and Micro Mold 02.03.21

    • Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase

      Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase

      Dr. Mark Ostwald of Freudenberg Medical speaks to the changes to the supply chain as well as the benefits realized in communication options.
      Dr. Mark Ostwald, President—Minimally Invasive Solutions and Europe, Freudenberg Medical 02.03.21


    • Perspectives on Post-Pandemic: For Manufacturers, Flexibility Is Key

      Perspectives on Post-Pandemic: For Manufacturers, Flexibility Is Key

      MICRO’s Steve Santoro comments on how medtech suppliers need to be nimble and solution-oriented for customers to ensure success.
      Steve Santoro, Executive Vice President, MICRO 02.03.21

    • Perspectives on Post-Pandemic: Collaboration Tools Mean Stronger Partnerships

      Perspectives on Post-Pandemic: Collaboration Tools Mean Stronger Partnerships

      Aaron Johnson of Accumold shares his thoughts on how new ways of connecting will result in better relationships in the supply chain.
      Aaron Johnson, Vice President of Marketing and Customer Strategy, Accumold 02.03.21

    • Perspectives on Post-Pandemic: Use Lessons Learned from EUAs

      Perspectives on Post-Pandemic: Use Lessons Learned from EUAs

      Curtis Hawkins of Canon Virginia hopes to see changes established from lessons learned during the pandemic to improve processes.
      Curtis Hawkins, Vice President—Business Operations Group, Canon Virginia Inc. 02.03.21


    • Diagnostics
      Perspectives on Post-Pandemic: Improvements in Diagnostics Technologies

      Perspectives on Post-Pandemic: Improvements in Diagnostics Technologies

      Christian Herrild of Teel Plastics expects better sample collection and diagnostic elements as wide-scale testing enhancements emerge.
      Christian Herrild, Dir. Growth Strategies, Teel Plastics 02.03.21

    • Perspectives on Post-Pandemic: Communication Changes to Stay

      Perspectives on Post-Pandemic: Communication Changes to Stay

      MicroSpec’s Tim Steele sees advantages to the way communication was accomplished during the pandemic.
      Tim Steele, Founder/Owner, MicroSpec Corporation 02.03.21

    • Perspectives on Post-Pandemic: Implement Best Practices from Rapid Response

      Perspectives on Post-Pandemic: Implement Best Practices from Rapid Response

      maxon's Peter van Beek recognizes the lessons learned from the urgent need of critical components could aid future supply.
      Peter van Beek, Business Development Manager—Medical, maxon 02.03.21


    Trending
    • Plastikos Medical Begins Phase II Of Expansion
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • FDA Clears ENvizion's Personalized Feeding Tube Placement Device
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Cheetah Medical Introduces Noninvasive Monitoring System
    Breaking News
    • Cretex CFO Announces Retirement
    • New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    • First Reported Use of Pulse Biosciences' CellFX System
    • EUA Granted for New COVID-19, Flu A, Flu B Combo Kit
    • EchoNous Expands Its Kosmos Hardware Platform
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Stressed Testing: Challenges with Medical Device Testing
    • Resourceful Resources: Materials Make a Difference During the Pandemic
    • Diagnostic Desperation: A Look at IVD Trends During COVID-19
    • Digitize Your QMS via an Enterprise Cloud Platform
    • Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President and COO
    Ashland Completes Expansion and Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login